Page 1 of Clinical Trials for Janssen-Cilag International NV [SPONSOR-COLLABORATORS], 32 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
Last Updated: December 23, 2011
Condition(s): HIV Infections; AIDS Virus; Human Immunodeficiency Virus; Acquired Immunodeficiency Syndrome Virus
2
Recruiting
A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment
Last Updated: May 18, 2012
Condition(s): Human Immunodeficiency Virus (HIV) Infections; Acquired Immunodeficiency Syndrome (AIDS) Virus
3
Recruiting
An Efficacy Study for Epoetin Alfa in Anemic Patients With Myelodysplastic Syndromes
Last Updated: March 12, 2012
Condition(s): Myelodysplastic Syndromes
4
Active, not recruiting
A Trial to Explore the Tolerability, Safety and Effectiveness of Paliperidone ER (Extended Release) Flexible Dosing in Patients With Schizophrenia
Last Updated: May 4, 2012
Condition(s): Schizophrenia
5
Recruiting
Telaprevir Open-Label Study in Co-Infected Patients
Last Updated: May 24, 2012
Condition(s): Hepatitis C, Chronic
6
Recruiting
PALMFlexS: Paliperidone Palmitate Flexible Dosing in Schizophrenia
Last Updated: May 18, 2012
Condition(s): Schizophrenia
7
Completed
A Trial to Explore the Tolerability, Safety and Treatment Response of the Antipsychotic Paliperidone ER (Extended Release) Using Flexible Dosing in Patients With Acute Schizophrenia
Last Updated: April 1, 2010
Condition(s): Schizophrenia
8
Active, not recruiting
Treatment With Velcade (Bortezomib) Plus Dexamethasone (VD) or VD Plus Cyclophosphamide or VD Plus Lenalidomide in Patients With Multiple Myeloma Stabilized After 4 Cycles of VD
Last Updated: June 30, 2011
Condition(s): Multiple Myeloma
9
Completed
Expanded Access Protocol (EAP) to Provide Bortezomib to Patients With Multiple Myeloma Who Have Received at Least 2 Previous Lines of Therapy and Are Refractory to or Have Relapsed After Their Last Therapy for Multiple Myeloma
Last Updated: October 19, 2007
Condition(s): Multiple Myeloma
10
Completed
Effect of Ceftobiprole on Human Intestinal Microflora
Last Updated: February 14, 2012
Condition(s): Antimicrobial Agent; Cephalosporins; Health; Drug Resistance
11
Completed
Velcade (Bortezomib), Adriamycin Dexamethasone (PAD) or Vincristine Adriamycin Dexamethasone in Second Line Treatment of Multiple Myeloma
Last Updated: May 28, 2009
Condition(s): Multiple Myeloma
12
Active, not recruiting
Open-Label, Bridging Study of Telaprevir in Treatment-Naïve and Treatment-Experienced Russian Patients With Genotype 1 Chronic Hepatitis C
Last Updated: April 27, 2012
Condition(s): Genotype 1 Chronic Hepatitis C
13
Completed
Bortezomib Retreatment in Multiple Myeloma
Last Updated: February 25, 2010
Condition(s): Multiple Myeloma
14
Active, not recruiting
Prevention of Relapse With Oral Antipsychotics Versus Injectable Paliperidone Palmitate (PROSIPAL)
Last Updated: May 15, 2012
Condition(s): Schizophrenia
15
Completed
A Safety and Efficacy Study of Ustekinumab in Patients With Plaque Psoriasis Who Have Had an Inadequate Response to Methotrexate
Last Updated: March 13, 2012
Condition(s): Psoriasis
16
Completed
A Study of Relapse Prevention and the Effectiveness of Long-acting Injectable Risperidone and Quetiapine Tablets in the Treatment of Patients With Schizophrenia or Schizoaffective Disorder
Last Updated: May 17, 2011
Condition(s): Schizophrenia; Psychotic Disorders
17
Completed
A Study to Compare Patient-controlled Pain Medications Delivered Either Through the Skin or Intravenously
Last Updated: April 26, 2010
Condition(s): Pain; Analgesia, Patient-controlled; Pain, Postoperative
18
Recruiting
Velcade Consolidation Bone Study
Last Updated: May 24, 2012
Condition(s): Multiple Myeloma
19
Completed
Observational Study (This Means That no Drug is Tested) in Patients Suffering of Gastroesophageal Reflux Disease
Last Updated: May 17, 2012
Condition(s): Gastroesophageal Reflux Disease; Gastro-oesophageal Reflux; Gastro-Esophageal Reflux; Esophageal Reflux; GERD
20
Completed
A Clinical Trial Comparing the Tolerability of Etravirine to Efavirenz in Combination With 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Treatment-naive HIV-1 Infected Patients
Last Updated: April 26, 2011
Condition(s): HIV Infection; HIV; Acquired Immunodeficiency Syndrome

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Janssen-Cilag+International+NV

Page 1 of Clinical Trials for Janssen-Cilag International NV [SPONSOR-COLLABORATORS], 32 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About